To anyone who still believes the safe and effective narrative. There's now more than 1000 studies that shows the exact opposite.
Severe adverse events including sudden death happens to 1 in 35.
Cerebral venous thrombosis after COVID-19 vaccination in the UK: a multicentre cohort study:
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01608-1/Vaccine-induced immune thrombotic thrombocytopenia with disseminated intravascular coagulation and death after ChAdOx1 nCoV-19 vaccination:
https://www.sciencedirect.com/science/article/pii/S1052305721003414Fatal cerebral hemorrhage after COVID-19 vaccine:
https://pubmed.ncbi.nlm.nih.gov/33928772/Myocarditis after mRNA vaccination against SARS-CoV-2, a case series:
https://www.sciencedirect.com/science/article/pii/S2666602221000409Three cases of acute venous thromboembolism in women after vaccination against COVID-19:
https://www.sciencedirect.com/science/article/pii/S2213333X21003929Acute thrombosis of the coronary tree after vaccination against COVID-19:
https://www.sciencedirect.com/science/article/abs/pii/S1936879821003988US case reports of cerebral venous sinus thrombosis with thrombocytopenia after vaccination with Ad26.COV2.S (against covid-19), March 2 to April 21, 2020:
https://pubmed.ncbi.nlm.nih.gov/33929487/Portal vein thrombosis associated with ChAdOx1 nCov-19 vaccine:
https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00197-7/Management of cerebral and splanchnic vein thrombosis associated with thrombocytopenia in subjects previously vaccinated with Vaxzevria (AstraZeneca): position statement of the Italian Society for the Study of Hemostasis and Thrombosis (SISET):
https://pubmed.ncbi.nlm.nih.gov/33871350/Vaccine-induced immune immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis after vaccination with COVID-19; a systematic review:
https://www.sciencedirect.com/science/article/pii/S0022510X21003014Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines:
https://www.sciencedirect.com/science/article/abs/pii/S0735675721004381Covid-19 vaccine-induced thrombosis and thrombocytopenia: a commentary on an important and practical clinical dilemma:
https://www.sciencedirect.com/science/article/abs/pii/S0033062021000505Thrombosis with thrombocytopenia syndrome associated with COVID-19 viral vector vaccines:
https://www.sciencedirect.com/science/article/abs/pii/S0953620521001904COVID-19 vaccine-induced immune-immune thrombotic thrombocytopenia: an emerging cause of splanchnic vein thrombosis:
https://www.sciencedirect.com/science/article/pii/S1665268121000557The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic immune thrombocytopenia (covid):
https://www.sciencedirect.com/science/article/pii/S1050173821000967Roots of autoimmunity of thrombotic events after COVID-19 vaccination:
https://www.sciencedirect.com/science/article/abs/pii/S1568997221002160Cerebral venous sinus thrombosis after vaccination: the United Kingdom experience:
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01788-8/fulltextThrombotic immune thrombocytopenia induced by SARS-CoV-2 vaccine:
https://www.nejm.org/doi/full/10.1056/nejme2106315Myocarditis after immunization with COVID-19 mRNA vaccines in members of the US military. This article reports that in “23 male patients, including 22 previously healthy military members, myocarditis was identified within 4 days after receipt of the vaccine”:
https://jamanetwork.com/journals/jamacardiology/fullarticle/2781601Thrombosis and thrombocytopenia after vaccination with ChAdOx1 nCoV-19:
https://www.nejm.org/doi/full/10.1056/NEJMoa2104882?query=recirc_curatedRelated_articleAssociation of myocarditis with the BNT162b2 messenger RNA COVID-19 vaccine in a case series of children:
https://pubmed.ncbi.nlm.nih.gov/34374740/Thrombotic thrombocytopenia after vaccination with ChAdOx1 nCov-19:
https://www.nejm.org/doi/full/10.1056/NEJMoa2104840?query=recirc_curatedRelated_articlePost-mortem findings in vaccine-induced thrombotic thrombocytopenia (covid-19):
https://haematologica.org/article/view/haematol.2021.279075Thrombocytopenia, including immune thrombocytopenia after receiving COVID-19 mRNA vaccines reported to the Vaccine Adverse Event Reporting System (VAERS):
https://www.sciencedirect.com/science/article/pii/S0264410X21005247Acute symptomatic myocarditis in seven adolescents after Pfizer-BioNTech COVID-19 vaccination:
https://pediatrics.aappublications.org/content/early/2021/06/04/peds.2021-052478Aphasia seven days after the second dose of an mRNA-based SARS-CoV-2 vaccine. Brain MRI revealed an intracerebral hemorrhage (ICBH) in the left temporal lobe in a 52-year-old man.
https://www.sciencedirect.com/science/article/pii/S2589238X21000292#f0005Comparison of vaccine-induced thrombotic episodes between ChAdOx1 nCoV-19 and Ad26.COV.2.S vaccines:
https://www.sciencedirect.com/science/article/abs/pii/S0896841121000895Hypothesis behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination:
https://www.sciencedirect.com/science/article/abs/pii/S0049384821003315Blood clots and bleeding episodes after BNT162b2 and ChAdOx1 nCoV-19 vaccination: analysis of European data:
https://www.sciencedirect.com/science/article/pii/S0896841121000937Cerebral venous thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine:
https://www.sciencedirect.com/science/article/abs/pii/S1052305721003098Primary adrenal insufficiency associated with thrombotic immune thrombocytopenia induced by the Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine (VITT):
https://www.sciencedirect.com/science/article/pii/S0953620521002363Myocarditis and pericarditis after vaccination with COVID-19 mRNA: practical considerations for care providers:
https://www.sciencedirect.com/science/article/pii/S0828282X21006243“Portal vein thrombosis occurring after the first dose of SARS-CoV-2 mRNA vaccine in a patient with antiphospholipid syndrome”:
https://www.sciencedirect.com/science/article/pii/S2666572721000389Early results of bivalirudin treatment for thrombotic thrombocytopenia and cerebral venous sinus thrombosis after vaccination with Ad26.COV2.S:
https://www.sciencedirect.com/science/article/pii/S0196064421003425Myocarditis, pericarditis and cardiomyopathy after COVID-19 vaccination:
https://www.sciencedirect.com/science/article/pii/S1443950621011562Mechanisms of immunothrombosis in vaccine-induced thrombotic thrombocytopenia (VITT) compared to natural SARS-CoV-2 infection:
https://www.sciencedirect.com/science/article/abs/pii/S0896841121000706Prothrombotic immune thrombocytopenia after COVID-19 vaccination:
https://www.sciencedirect.com/science/article/pii/S0006497121009411Vaccine-induced thrombotic thrombocytopenia: the dark chapter of a success story:
https://www.sciencedirect.com/science/article/pii/S2589936821000256Cerebral venous sinus thrombosis negative for anti-PF4 antibody without thrombocytopenia after immunization with COVID-19 vaccine in a non-comorbid elderly Indian male treated with conventional heparin-warfarin based anticoagulation:
https://www.sciencedirect.com/science/article/pii/S1871402121002046Thrombosis after COVID-19 vaccination: possible link to ACE pathways:
https://www.sciencedirect.com/science/article/pii/S0049384821004369Cerebral venous sinus thrombosis in the U.S. population after SARS-CoV-2 vaccination with adenovirus and after COVID-19:
https://www.sciencedirect.com/science/article/pii/S0735109721051949A rare case of a middle-aged Asian male with cerebral venous thrombosis after AstraZeneca COVID-19 vaccination:
https://www.sciencedirect.com/science/article/pii/S0735675721005714Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination: report of two cases in the United Kingdom:
https://www.sciencedirect.com/science/article/abs/pii/S088915912100163XImmune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19):
https://www.sciencedirect.com/science/article/abs/pii/S0006497121013963.
Antiphospholipid antibodies and risk of thrombophilia after COVID-19 vaccination: the straw that breaks the camel’s back?:
https://docs.google.com/document/d/1XzajasO8VMMnC3CdxSBKks1o7kiOLXFQVaccine-induced thrombotic thrombocytopenia, a rare but severe case of friendly fire in the battle against the COVID-19 pandemic: What pathogenesis?:
https://www.sciencedirect.com/science/article/pii/S0953620521002314Diagnostic-therapeutic recommendations of the ad-hoc FACME expert working group on the management of cerebral venous thrombosis related to COVID-19 vaccination:
https://www.sciencedirect.com/science/article/pii/S0213485321000839Thrombocytopenia and intracranial venous sinus thrombosis after exposure to the “AstraZeneca COVID-19 vaccine”:
https://pubmed.ncbi.nlm.nih.gov/33918932/Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination:
https://pubmed.ncbi.nlm.nih.gov/33606296/Severe and refractory immune thrombocytopenia occurring after SARS-CoV-2 vaccination:
https://pubmed.ncbi.nlm.nih.gov/33854395/Purpuric rash and thrombocytopenia after mRNA-1273 (Modern) COVID-19 vaccine:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996471/COVID-19 vaccination: information on the occurrence of arterial and venous thrombosis using data from VigiBase:
https://pubmed.ncbi.nlm.nih.gov/33863748/Cerebral venous thrombosis associated with the covid-19 vaccine in Germany:
https://onlinelibrary.wiley.com/doi/10.1002/ana.26172Cerebral venous thrombosis following BNT162b2 mRNA vaccination of BNT162b2 against SARS-CoV-2: a black swan event:
https://pubmed.ncbi.nlm.nih.gov/34133027/The importance of recognizing cerebral venous thrombosis following anti-COVID-19 vaccination:
https://pubmed.ncbi.nlm.nih.gov/34001390/Thrombosis with thrombocytopenia after messenger RNA vaccine -1273:
https://pubmed.ncbi.nlm.nih.gov/34181446/Blood clots and bleeding after BNT162b2 and ChAdOx1 nCoV-19 vaccination: an analysis of European data:
https://pubmed.ncbi.nlm.nih.gov/34174723/First dose of ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic, and hemorrhagic events in Scotland:
https://www.nature.com/articles/s41591-021-01408-4Exacerbation of immune thrombocytopenia after COVID-19 vaccination:
https://pubmed.ncbi.nlm.nih.gov/34075578/First report of a de novo iTTP episode associated with a COVID-19 mRNA-based anti-COVID-19 vaccine:
https://pubmed.ncbi.nlm.nih.gov/34105244/PF4 immunoassays in vaccine-induced thrombotic thrombocytopenia:
https://www.nejm.org/doi/full/10.1056/NEJMc2106383Antibody epitopes in vaccine-induced immune immune thrombotic thrombocytopenia:
https://www.nature.com/articles/s41586-021-03744-4Myocarditis with COVID-19 mRNA vaccines:
https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.121.056135Myocarditis and pericarditis after COVID-19 vaccination:
https://jamanetwork.com/journals/jama/fullarticle/2782900Myocarditis temporally associated with COVID-19 vaccination:
https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.121.055891.
COVID-19 Vaccination Associated with Myocarditis in Adolescents:
https://pediatrics.aappublications.org/content/pediatrics/early/2021/08/12/peds.2021-053427.full.pdfAcute myocarditis after administration of BNT162b2 vaccine against COVID-19:
https://pubmed.ncbi.nlm.nih.gov/33994339/Temporal association between COVID-19 vaccine Ad26.COV2.S and acute myocarditis: case report and review of the literature:
https://www.sciencedirect.com/science/article/pii/S1553838921005789COVID-19 vaccine-induced myocarditis: a case report with review of the literature:
https://www.sciencedirect.com/science/article/pii/S1871402121002253Potential association between COVID-19 vaccine and myocarditis: clinical and CMR findings:
https://www.sciencedirect.com/science/article/pii/S1936878X2100485XRecurrence of acute myocarditis temporally associated with receipt of coronavirus mRNA disease vaccine 2019 (COVID-19) in a male adolescent:
https://www.sciencedirect.com/science/article/pii/S002234762100617XFulminant myocarditis and systemic hyper inflammation temporally associated with BNT162b2 COVID-19 mRNA vaccination in two patients:
https://www.sciencedirect.com/science/article/pii/S0167527321012286.
Acute myocarditis after administration of BNT162b2 vaccine:
https://www.sciencedirect.com/science/article/pii/S2214250921001530Lymphohistocytic myocarditis after vaccination with COVID-19 Ad26.COV2.S viral vector:
https://www.sciencedirect.com/science/article/pii/S2352906721001573Myocarditis following vaccination with BNT162b2 in a healthy male:
https://www.sciencedirect.com/science/article/pii/S0735675721005362Acute myocarditis after Comirnaty (Pfizer) vaccination in a healthy male with previous SARS-CoV-2 infection:
https://www.sciencedirect.com/science/article/pii/S1930043321005549Myopericarditis after Pfizer mRNA COVID-19 vaccination in adolescents:
https://www.sciencedirect.com/science/article/pii/S002234762100665XPericarditis after administration of BNT162b2 mRNA COVID-19 mRNA vaccine:
https://www.sciencedirect.com/science/article/pii/S1885585721002218Acute myocarditis after vaccination with SARS-CoV-2 mRNA-1273 mRNA:
https://www.sciencedirect.com/science/article/pii/S2589790X21001931Temporal relationship between the second dose of BNT162b2 mRNA Covid-19 vaccine and cardiac involvement in a patient with previous SARS-COV-2 infection:
https://www.sciencedirect.com/science/article/pii/S2352906721000622Myopericarditis after vaccination with COVID-19 mRNA in adolescents 12 to 18 years of age:
https://www.sciencedirect.com/science/article/pii/S0022347621007368Acute myocarditis after SARS-CoV-2 vaccination in a 24-year-old man:
https://www.sciencedirect.com/science/article/pii/S0870255121003243Important information on myopericarditis after vaccination with Pfizer COVID-19 mRNA in adolescents:
https://www.sciencedirect.com/science/article/pii/S0022347621007496A series of patients with myocarditis after vaccination against SARS-CoV-2 with mRNA-1279 and BNT162b2:
https://www.sciencedirect.com/science/article/pii/S1936878X21004861Takotsubo cardiomyopathy after vaccination with mRNA COVID-19:
https://www.sciencedirect.com/science/article/pii/S1443950621011331COVID-19 mRNA vaccination and myocarditis:
https://pubmed.ncbi.nlm.nih.gov/34268277/COVID-19 vaccine and myocarditis:
https://pubmed.ncbi.nlm.nih.gov/34399967/Epidemiology and clinical features of myocarditis/pericarditis before the introduction of COVID-19 mRNA vaccine in Korean children: a multicenter study
https://search.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resourc e/en/covidwho-1360706.
COVID-19 vaccines and myocarditis:
https://pubmed.ncbi.nlm.nih.gov/34246566/Myocarditis and other cardiovascular complications of COVID-19 mRNA-based COVID-19 vaccines
https://www.cureus.com/articles/61030-myocarditis-and-other-cardiovascular-comp lications-of-the-mrna-based-covid-19-vaccines
https://www.cureus.com/articles/61030-myocarditis-and-other-cardiovascular-complications-of-the-mrna-based-covid-19-vaccinesMyocarditis, pericarditis, and cardiomyopathy after COVID-19 vaccination:
https://pubmed.ncbi.nlm.nih.gov/34340927/Myocarditis with covid-19 mRNA vaccines:
https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.056135Association of myocarditis with COVID-19 mRNA vaccine in children:
https://media.jamanetwork.com/news-item/association-of-myocarditis-with-mrna-co vid-19-vaccine-in-children/
Association of myocarditis with COVID-19 messenger RNA vaccine BNT162b2 in a case series of children:
https://jamanetwork.com/journals/jamacardiology/fullarticle/2783052Myocarditis after immunization with COVID-19 mRNA vaccines in members of the U.S. military:
https://jamanetwork.com/journals/jamacardiology/fullarticle/2781601%5CMyocarditis occurring after immunization with COVID-19 mRNA-based COVID-19 vaccines:
https://jamanetwork.com/journals/jamacardiology/fullarticle/2781600Myocarditis following immunization with Covid-19 mRNA:
https://www.nejm.org/doi/full/10.1056/NEJMc2109975Patients with acute myocarditis after vaccination withCOVID-19 mRNA:
https://jamanetwork.com/journals/jamacardiology/fullarticle/2781602Myocarditis associated with vaccination with COVID-19 mRNA:
https://pubs.rsna.org/doi/10.1148/radiol.2021211430Symptomatic Acute Myocarditis in 7 Adolescents after Pfizer-BioNTech COVID-19 Vaccination:
https://pediatrics.aappublications.org/content/148/3/e2021052478Cardiovascular magnetic resonance imaging findings in young adult patients with acute myocarditis after COVID-19 mRNA vaccination.
Clinical Guidance for Young People with Myocarditis and Pericarditis after Vaccination with COVID-19 mRNA:
https://www.cps.ca/en/documents/position/clinical-guidance-for-youth-with-myocarditis-and-pericarditisCardiac imaging of acute myocarditis after vaccination with COVID-19 mRNA:
https://pubmed.ncbi.nlm.nih.gov/34402228/Case report: acute myocarditis after second dose of mRNA-1273 SARS-CoV-2 mRNA vaccine:
https://academic.oup.com/ehjcr/article/5/8/ytab319/6339567Myocarditis / pericarditis associated with COVID-19 vaccine:
https://science.gc.ca/eic/site/063.nsf/eng/h_98291.htmlTransient cardiac injury in adolescents receiving the BNT162b2 mRNA COVID-19 vaccine:
https://journals.lww.com/pidj/Abstract/9000/Transient_Cardiac_Injury_in_Adolesce nts_Receiving.